What Is Johnson & Johnson (JNJ) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Johnson & Johnson's intrinsic value is estimated at $118.02. Trading at its current price of $257.97, the valuation engine raises significant caution: 12 of 12 models flag downside risk, projecting an average implied return of -54.3%. Notably, PWERM sees the most upside at -12.0% (fair value: $226.92), while ML-RIV is the most conservative at -92.8% ($18.55). The spread between these extremes — +80.8% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.
What Do the Models Say About JNJ?
12 of 13 models are currently active for JNJ. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates JNJ's intrinsic value at $76.23, implying -70.5% downside from the current price. See which stocks rank higher →
How Does JNJ Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, JNJ ranks #19 by Quality of Company score. CirclFi's QOC score of 8.9/10 evaluates 32 fundamental signals. A score of 8.9 places JNJ in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Johnson & Johnson's positioning within the Pharmaceutical Preparations segment means that clinical trial success rate plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.
Is JNJ a Value Trap?
CirclFi's Value Trap algorithm assigns JNJ a score of 17/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Johnson & Johnson. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Johnson & Johnson scores 8.9 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +80.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every JNJ valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across JNJ's 12 active models, average confidence is 54%. Moderate confidence indicates reasonable fit.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad